Riskpilot← Back to searchSign inGet full accessSMEDCON AB
ABActiveOrg 5591322309Talgoxevägen 39 BBusiness and other management consultancy activities · NACE 7020Est. 20170 employees
Revenue 2025
SEK -2
EBITDA margin
499550.0%
+60% vs 2024
Equity ratio
75.6%
Financial strength
Net profit 2025
SEK -10K
-88% vs 2024
| Revenue | SEK -2 | — |
| EBITDA | SEK -10K | +60% |
| Net profit | SEK -10K | -88% |
| Total assets | SEK 46K | -18% |
| Equity | SEK 35K | -22% |
| Employees | 0 | — |
Legal name
SMEDCON AB
Org number
5591322309
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
6 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget bedriver konsultverksamhet inom företagsledning och försäljning, levereras antingen i en operativ roll på företaget eller projektbaserat. Aktiebolaget bedriver också en återförsäljarverksamhet med handel av varor mellan Vietnam och Sverige inom byggmaterial och livsmedel.
Address
Talgoxevägen 39 B
Email
smedberg.anders@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | −0 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | −10 | −8 | −2 | −25 | −10 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −10 | −8 | −2 | −25 | −10 |
| Net financials | — | — | −0 | — | — |
| Profit before tax | 0 | 6 | −0 | −5 | −10 |
| Tax | −0 | — | — | — | — |
| Net profit | 0 | 6 | −0 | −5 | −10 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 90 | 83 | 81 | 56 | 46 |
| Equity | 44 | 51 | 50 | 45 | 35 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 11 | 11 | 11 | 11 | 11 |
| Total debt | 11 | 11 | 11 | 11 | 11 |
EBITDA margin
-999100.0%
This company
15.8%
Market median
-6323518% vs market
20212025
Equity ratio
75.6%
This company
38.2%
Market median
+98% vs market
20212025
Return on equity
-28.6%
This company
18.4%
Market median
-255% vs market
20212025
Net profit margin
-999100.0%
This company
8.1%
Market median
-12334668% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SMEDCON AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Patrik Engdahl | Deputy Board Member | 0 companies |
| Anders Erik Smedberg | Board of Directors | 0 companies |